GP
GW Pharmaceuticals
GW Pharmaceuticals Limited is a British pharmaceutics company known for its multiple sclerosis treatment product nabiximols which was the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, was approved for treatment of epilepsy by the US Food and Drug Administration in 2018. It is a subsidiary of Jazz Pharmaceuticals.
Last 30 days1Stories1Articles0Events
30-day activity pulse
Last 7d articles
1
Prior 7d baseline
0
Trend
new
Peak day
1
Peak article volume on 2026-05-16.
Last 24 hoursStories, events, map, and sources are limited to the past 24 hours. Use the Wikipedia link or the API for deeper history.
Event Timeline
No linked events in the last 24 hours.